What are the next steps for a patient with linear T2 (T2-weighted imaging) and FLAIR (Fluid-Attenuated Inversion Recovery) hyper signal intensity in the anterior left centrum semiovale and adjacent small Developmental Venous Anomaly (DVA) favoring facial gliosis on MRI (Magnetic Resonance Imaging) brain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Linear T2/FLAIR Hyperintensity in Left Centrum Semiovale with Adjacent DVA

The finding of linear T2 and FLAIR hyperintensity in the centrum semiovale adjacent to a developmental venous anomaly (DVA) most likely represents focal gliosis related to chronic venous congestion, and the primary next step is clinical correlation with neurological symptoms followed by short-interval follow-up MRI in 3-6 months to establish stability. 1

Initial Clinical Assessment

Determine if the patient has any neurological symptoms:

  • New or progressive headaches, seizures, focal neurological deficits, or cognitive changes require more urgent evaluation 2
  • Asymptomatic findings discovered incidentally can be managed more conservatively with imaging follow-up 1

Key clinical context to obtain:

  • History of seizures or epilepsy (DVAs can be associated with epileptogenic foci) 3
  • Recent infections, fever, or altered mental status that might suggest encephalitis 2
  • Immunosuppression status (particularly natalizumab use, HIV, or other immunocompromising conditions) 4
  • Age-related considerations, as T2 hyperintensities have different implications across age groups 3

Differential Diagnosis Considerations

The linear pattern adjacent to a DVA most strongly suggests:

  • Focal gliosis from chronic venous congestion (most likely given the anatomic relationship to the DVA) 1
  • Dilated perivascular spaces (though these typically appear more rounded) 1
  • Small vessel ischemic changes (less likely given the linear morphology and DVA association) 1

Less likely but important to exclude:

  • Early demyelinating disease (multiple sclerosis) - would typically show multiple lesions in characteristic periventricular and juxtacortical locations 4
  • Low-grade glioma - the T2-FLAIR mismatch sign (complete suppression of FLAIR signal) is highly specific for IDH-mutant astrocytomas, which is NOT present in this case 5, 6
  • Encephalitis - would typically show more extensive involvement, particularly of temporal lobes, and present with acute symptoms 2

Imaging Protocol for Follow-up

Obtain follow-up MRI in 3-6 months with the following sequences:

  • Thin-slice (≤1mm) 3D T1-weighted sequences 7
  • Axial and coronal T2-weighted sequences (≤3mm) 7
  • 3D FLAIR sequence with thin slices (≤1mm) for triplanar reformatting 3
  • Pre- and post-gadolinium T1-weighted sequences to assess for any enhancement 8
  • Diffusion-weighted imaging (DWI) to evaluate for restricted diffusion that might suggest acute pathology 3, 2

The key imaging features to assess on follow-up:

  • Stability of the lesion size and signal characteristics (stable findings over 3-6 months strongly favor benign gliosis) 1
  • Absence of contrast enhancement (enhancement would raise concern for neoplasm or active inflammation) 8
  • No new lesions appearing elsewhere in the brain 4
  • No mass effect or architectural distortion of surrounding structures 7

When to Pursue More Aggressive Workup

Consider lumbar puncture with CSF analysis if:

  • Patient develops new neurological symptoms suggesting encephalitis (altered consciousness, seizures, fever) 2
  • Multiple new lesions appear on follow-up imaging 4
  • There is clinical suspicion for demyelinating disease with appropriate clinical syndrome 4

Consider advanced imaging (perfusion MRI or amino acid PET) if:

  • The lesion demonstrates growth on follow-up imaging 8
  • There is disruption of grey-white matter architecture suggesting infiltrative tumor rather than simple gliosis 7
  • Contrast enhancement develops 8

Brain biopsy is NOT indicated in the initial assessment of this stable-appearing lesion, but may be considered if progressive changes occur without diagnosis after comprehensive imaging and CSF evaluation 2

Critical Pitfalls to Avoid

Do not immediately assume this represents a neoplastic process:

  • T2/FLAIR hyperintensities adjacent to DVAs are commonly benign findings related to chronic venous congestion 1
  • The linear morphology and association with a known DVA strongly favor a benign etiology 1

Do not overlook the DVA itself:

  • DVAs are benign developmental variants present in 2-3% of the population 1
  • They rarely require intervention unless associated with symptomatic venous hypertension or hemorrhage 1

Do not delay acyclovir if encephalitis is clinically suspected:

  • If the patient presents with fever, altered consciousness, or seizures, empiric acyclovir should be started immediately while awaiting diagnostic confirmation 2
  • However, the described imaging pattern (linear, adjacent to DVA, in centrum semiovale) is NOT typical for HSV encephalitis, which characteristically involves bilateral temporal lobes 2

Do not confuse this with T2-FLAIR mismatch sign:

  • True T2-FLAIR mismatch (complete FLAIR suppression with bright T2 signal) is highly specific for IDH-mutant, 1p/19q non-codeleted astrocytomas 5, 6
  • The described finding shows hyperintensity on BOTH T2 and FLAIR, which is the typical pattern for most pathologies 9

Monitoring Strategy

For asymptomatic patients with stable imaging:

  • Repeat MRI at 3-6 months initially 4, 8
  • If stable, extend to annual imaging for 2-3 years 4
  • Discontinue routine surveillance if findings remain completely stable after 2-3 years 1

For patients with new or progressive symptoms:

  • Obtain urgent MRI with contrast 8
  • Consider EEG if seizures are suspected 2
  • Pursue CSF analysis if inflammatory or infectious etiology is considered 2

References

Research

T2-hyperintense foci on brain MR imaging.

Medical science monitor : international medical journal of experimental and clinical research, 2004

Guideline

Approach to MRI Brain Suggestive of Early Features of Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2017

Guideline

MRI Sequences: T1 and T2 Weighted Imaging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management approach for a brain lesion identified on MRI (Magnetic Resonance Imaging) with or without contrast?
What is the differential diagnosis of periventricular hyperintensities on T2 (T2-weighted) FLAIR (Fluid-Attenuated Inversion Recovery) MRI in children?
Given MRI findings of nonspecific T2 hyperintensity in the spinal cord at L3‑L5, T2 hyperintensity in the cerebellar white matter, and a focal cervical disc herniation with foraminal stenosis, am I at serious risk (i.e., “cooked”) or can these findings be managed with treatment?
What is the treatment for minimal scattered white matter T2 hyperintensity on brain Magnetic Resonance Imaging (MRI)?
In a 22‑year‑old woman with brief, pulsating vertex headaches that started after discontinuing hormonal therapy and a solitary sub‑centimetre punctate T2‑FLAIR hyperintense lesion in the right supratentorial white matter of unknown etiology, what is the recommended management?
What is the cause of runner's itch in a relatively healthy individual who engages in regular running or strenuous exercise?
What is the purpose and interpretation of a 24-hour urine histamine test in patients suspected of having conditions associated with excessive histamine production, such as mastocytosis or carcinoid syndrome?
Can I give albumin (human albumin) to a patient with impaired renal function, as indicated by elevated Blood Urea Nitrogen (BUN) and creatinine levels, and hypotension (low blood pressure)?
Is it normal for one ovary to not be visible on ultrasound in a female patient of reproductive age?
When to use A2FN (femoral nail) versus PFNA (Proximal Femoral Nail Antirotation) in a patient with Charcot-Marie-Tooth disease type 2 and a femoral fracture?
What are the similarities between Latuda (lurasidone) and Caplyta (lumateperone) in the treatment of schizophrenia and bipolar depression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.